angiogenesis Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group
Sitenames

Any (1)

Phase 1 (1)

Interventional (1)

Shanghai Jiao Tong University School of Medicine (1)

No (1)

No (1)

Adult (18+) (1)

hospit (1)
ninth (1)
peopl (1)
shanghai (1)

I am/have/had

I am/have/hadtumor angiogenesis

I am/have/hadvascular endothelial growth factor receptor 2

I am/have/hadhead and neck squamous cell carcinoma

I am/have/hadrenal function

I am/have/hadleukocyte count

I am/have/hadcarcinoma

I am/have/hadmetastasis

I am/have/hadlymph node metastases

I am/have/hadtumor burden

I am/have/hadcancer

I am/have/hadimmunosuppression

I am/have/hadchemoradiotherapy

I am/have/hadvegf

I am/have/hadangiogenesis

I am/have/hadsquamous cell carcinoma of the head and neck

I am/have/hadtargeted therapy

I am/have/hadneovascularization

I am/have/hadtumor growth

I am/have/hadwhite blood cell count

I am/have/hadvascular endothelial growth factor

added new label for I am/have/had

more

I am looking for

I am looking forgrowth factor

I am looking forimmune checkpoint inhibitor

I am looking forvegf

I am looking forcamrelizumab

I am looking forvascular endothelial growth factor

I am looking forapatinib

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Dental/Oral Health
Recruiting

Inductive Camrelizumab and Apatinib for Patients With Locally Advanced and Resectable Oral Squamous Cell Carcinoma

After tumor hypoxia, high expression of VEGF will induce tumor cells to express programmed cell death protein-1 (PD-1), which further leads to immune escape. Targeted drugs against angiogenesis can relieve immunosuppression to a certain extent, and theoretically have a synergistic effect with anti-PD-1 immunotherapy.

growth factor

tumor angiogenesis

vascular endothelial growth factor receptor 2

apatinib

head and neck squamous cell carcinoma

0 views
05 Aug, 2020

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.